In the demanding world of pharmaceutical manufacturing, the quality of raw materials directly influences the safety, efficacy, and consistency of the final product. Omega-3 fatty acid esters, such as Docosahexaenoic Acid Ethyl Ester (DHA EE), are increasingly important ingredients used in the development of advanced therapeutics and nutritional supplements. For pharmaceutical companies, understanding the critical role of purity and securing a reliable supply of these specialized lipids is paramount.
Why Omega-3 Esters are Crucial in Pharmaceuticals
Omega-3 fatty acids, particularly DHA and EPA, are renowned for their beneficial effects on cardiovascular health, brain function, and inflammation. Their esterified forms, like DHA Ethyl Ester, offer enhanced stability and bioavailability, making them ideal for incorporation into pharmaceutical formulations and for use as intermediates in complex drug synthesis. The specific structure of DHA EE (C24H36O2, CAS 81926-94-5) provides a precise molecular building block for drug developers.
The pharmaceutical industry requires ingredients that meet rigorous purity standards. A minimum assay of 98.0% for DHA EE is often a prerequisite, ensuring that the material is free from significant contaminants that could compromise the integrity of the final drug product. Furthermore, stringent control over parameters like acid value (≤2 mgKOH/g) and peroxide levels (≤20 meq/kg) is essential to guarantee the stability and shelf-life of the active ingredients. Manufacturers who consistently meet these specifications are invaluable partners.
Securing a Reliable Supply Chain for DHA Ethyl Ester
For pharmaceutical manufacturers, establishing a robust and reliable supply chain for critical intermediates like DHA EE is a strategic imperative. This involves partnering with manufacturers who not only guarantee high-purity products but also possess the capacity for large-scale production and maintain consistent quality across batches. Sourcing from a direct manufacturer, often located in regions with strong chemical manufacturing infrastructure like China, can offer significant advantages in terms of cost and supply chain control.
When evaluating potential suppliers, pharmaceutical procurement teams should look for:
By prioritizing these factors, pharmaceutical manufacturers can ensure that their production processes are supported by the highest quality Omega-3 esters, ultimately contributing to the development of safe and effective medications. The strategic sourcing of Docosahexaenoic Acid Ethyl Ester is a vital step in maintaining product integrity and operational efficiency.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.